The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2024 | Challenges with designing clinical trials for smoldering myeloma
Eileen Boyle, MD, PhD, University College London, London, UK, highlights the challenges in designing clinical trials for smoldering multiple myeloma (SMM). She stresses the need for researchers to collaborate on identifying which patients should receive treatment, the appropriate treatment methods, and the impact of these trials on patients’ quality of life (QoL). This interview took place at The 10th World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
